zanamivir has been researched along with Renal Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, LS; Lou, Y; Ng-Cashin, J; Peppercorn, A; Weller, S | 1 |
| Ishizuka, H; Okabe, H; Yoshiba, S; Yoshihara, K | 1 |
| Bye, A; Cass, LM; Efthymiopoulos, C; Marsh, J | 1 |
3 trial(s) available for zanamivir and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of zanamivir following intravenous administration to subjects with and without renal impairment.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Creatinine; Female; Humans; Influenza, Human; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency; Young Adult; Zanamivir | 2013 |
Assessment of the effects of renal impairment on the pharmacokinetic profile of laninamivir, a novel neuraminidase inhibitor, after a single inhaled dose of its Prodrug, CS-8958.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Area Under Curve; Enzyme Inhibitors; Female; Guanidines; Half-Life; Humans; Male; Middle Aged; Neuraminidase; Prodrugs; Pyrans; Renal Insufficiency; Severity of Illness Index; Sialic Acids; Zanamivir | 2011 |
Effect of renal impairment on the pharmacokinetics of intravenous zanamivir.
Topics: Adult; Aged; Antiviral Agents; Chromatography, High Pressure Liquid; Drug Evaluation; Female; Guanidines; Humans; Injections, Intravenous; Kidney; Male; Middle Aged; Pyrans; Renal Insufficiency; Safety; Sialic Acids; Zanamivir | 1999 |